Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial - Gerstein, H C; Colhoun, H M; Dagenais, G R
Lancet [Internet]. 2019 Jun 7 [cited 2019 Jun 15]; Available from: